AU2635797A - Expression of hgv antigens and their use - Google Patents

Expression of hgv antigens and their use

Info

Publication number
AU2635797A
AU2635797A AU26357/97A AU2635797A AU2635797A AU 2635797 A AU2635797 A AU 2635797A AU 26357/97 A AU26357/97 A AU 26357/97A AU 2635797 A AU2635797 A AU 2635797A AU 2635797 A AU2635797 A AU 2635797A
Authority
AU
Australia
Prior art keywords
hgv
expression
von
zur
herstellung
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26357/97A
Inventor
Alfred Engel
Michael Tacke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of AU2635797A publication Critical patent/AU2635797A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Es werden neue Verfahren zur rekombinanten Herstellung von Hepatitis-G-Virus Antigenen in membrangebundener und löslicher Form sowie deren Verwendung zum diagnostischen Nachweis von HGV offenbart. Zur Herstellung der Antigene wird vorzugsweise eine eukaryontische Wirtszelle verwendet.
AU26357/97A 1996-04-03 1997-04-02 Expression of hgv antigens and their use Abandoned AU2635797A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19613406A DE19613406A1 (en) 1996-04-03 1996-04-03 Expression of HGV antigens and their use
DE19613406 1996-04-03
PCT/EP1997/001649 WO1997038108A1 (en) 1996-04-03 1997-04-02 Expression of hgv antigens and their use

Publications (1)

Publication Number Publication Date
AU2635797A true AU2635797A (en) 1997-10-29

Family

ID=7790416

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26357/97A Abandoned AU2635797A (en) 1996-04-03 1997-04-02 Expression of hgv antigens and their use

Country Status (7)

Country Link
EP (1) EP0891427B1 (en)
JP (1) JP2000510329A (en)
AT (1) ATE243255T1 (en)
AU (1) AU2635797A (en)
DE (2) DE19613406A1 (en)
ES (1) ES2201289T3 (en)
WO (1) WO1997038108A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004108159A2 (en) * 2003-06-05 2004-12-16 The University Of Iowa Research Foundation Gb virus c (hepatitis g virus) for the treatment of hiv

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156495A (en) * 1994-02-14 2000-12-05 Abbott Laboratories Hepatitis GB virus recombinant proteins and uses thereof
CA2166313A1 (en) * 1994-02-14 1995-08-17 John N. Simons Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
ATE210185T1 (en) * 1994-05-20 2001-12-15 Genelabs Tech Inc HEPATITIS G VIRUS AND ITS MOLECULAR CLONING

Also Published As

Publication number Publication date
WO1997038108A1 (en) 1997-10-16
DE59710308D1 (en) 2003-07-24
EP0891427B1 (en) 2003-06-18
ES2201289T3 (en) 2004-03-16
EP0891427A1 (en) 1999-01-20
DE19613406A1 (en) 1997-10-09
JP2000510329A (en) 2000-08-15
ATE243255T1 (en) 2003-07-15

Similar Documents

Publication Publication Date Title
CA2199993A1 (en) Methods of delivering materials into the skin, and compositions used therein
DE69713336D1 (en) Process for the production of activated labeled tumor-specific T cells and their use in the treatment of tumors
DE69209300D1 (en) PARTICLE-COVERED PARTICLES FOR USE IN COSMETIC COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
AU5785490A (en) Method and composition to impart improved conditioning properties to the hair
EP2270046A3 (en) Methods and compositions for the treatment of hemolysis-associated diseases
DE69426374D1 (en) Aromatic or perfume concentrate for mouthwash in the form of an oil-in-water microemulsion, and process for making the same
DE59503593D1 (en) Process for the preparation of water-dilutable urethane resins and their use
DE59306638D1 (en) Process for the preparation of 2,2,6,6-tetramethylpiperidine-N-oxyl and derivatives substituted in its 4-position
DE3784611D1 (en) AUREOBASIDIUM SP. MICROORGANISMS AND THEIR USE IN THE METHOD FOR PRODUCING ERYTHRITOL.
DE69526863D1 (en) NEW 1,2-DIOXETANES WITH HALOALCOXY GROUPS, METHOD FOR THE PRODUCTION AND USE
DE69007625D1 (en) ABSORBENT MEDIUM COMPOSITION AND METHOD FOR PRODUCING THE SAME.
ATE219767T1 (en) METHOD FOR PRODUCING 2,4-DIHYDROXY-PYRIDINE AND 2,4-DIHYDROXY-3-NITROPYRIDINE
DE69107031D1 (en) Thexyl-trialkoxysilanes, process for their preparation and their use.
DE59205279D1 (en) Temperature-stable black pigment, process for its preparation and its use
DE69613964D1 (en) METHOD FOR PRODUCING PENTAFLUOROETHANE AND TETRAFLUOROCHLOROETHANE
DE69321848D1 (en) METHOD FOR PRODUCING 1,1,1,2,3,3-HEXAFLUORPROPANE AND TETRAFLUORCHLOROPROPEN
DE59001156D1 (en) METHOD FOR THE PRODUCTION OF MUSCON, INTERMEDIATE PRODUCTS FOR THIS METHOD AND THE PRODUCTION THEREOF.
DE69400342D1 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethane and pentafluoroethane
DE69303302D1 (en) Process for the production of neotrehalose and its uses
DE68917154D1 (en) C-TERMINUS AMIDATING ENZYME COMPOSITION, METHOD FOR THE PRODUCTION AND USE.
DE3575743D1 (en) METHOD FOR OBTAINING MICROORGANISMS CONTAINING PHENYLALANINE DEHYDROGENASE AND THE USE THEREOF FOR PRODUCING L-ALPHA AMINO ACIDS.
DE59606567D1 (en) New microorganism, its use and process for the production of L-alpha amino acids
ZA976209B (en) Composition for the oxidation dyeing of keratin fibres and dyeing process using them.
AU2635797A (en) Expression of hgv antigens and their use
DE69205535D1 (en) Process for the preparation of phenylbutyronitriles and use in the perfumery of 2,2-dimethyl-4-phenyl-valeriannitrile.